Literature DB >> 24366917

Secondary arterial hypertension: when, who, and how to screen?

Stefano F Rimoldi1, Urs Scherrer2, Franz H Messerli3.   

Abstract

Secondary hypertension refers to arterial hypertension due to an identifiable cause and affects ∼5-10% of the general hypertensive population. Because secondary forms are rare and work up is time-consuming and expensive, only patients with clinical suspicion should be screened. In recent years, some new aspects gained importance regarding this screening. In particular, increasing evidence suggests that 24 h ambulatory blood pressure (BP) monitoring plays a central role in the work up of patients with suspected secondary hypertension. Moreover, obstructive sleep apnoea has been identified as one of the most frequent causes. Finally, the introduction of catheter-based renal denervation for the treatment of patients with resistant hypertension has dramatically increased the interest and the number of patients evaluated for renal artery stenosis. We review the clinical clues of the most common causes of secondary hypertension. Specific recommendations are given as to evaluation and treatment of various forms of secondary hypertension. Despite appropriate therapy or even removal of the secondary cause, BP rarely ever returns to normal with long-term follow-up. Such residue hypertension indicates either that some patients with secondary hypertension also have concomitant essential hypertension or that irreversible vascular remodelling has taken place. Thus, in patients with potentially reversible causes of hypertension, early detection and treatment are important to minimize/prevent irreversible changes in the vasculature and target organs. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2013. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arterial hypertension; Obstructive sleep apnoea; Pheochromocytoma; Primary aldosteronism; Renal artery stenosis; Secondary hypertension

Mesh:

Substances:

Year:  2013        PMID: 24366917     DOI: 10.1093/eurheartj/eht534

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  53 in total

Review 1.  Multidisciplinary Approach in the Treatment of Resistant Hypertension.

Authors:  S A Potthoff; O Vonend
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

2.  Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs.

Authors:  Yoon Young Cho; Kee-Ho Song; Young Nam Kim; Seong Hee Ahn; Hyeonmok Kim; Sooyoun Park; Sunghwan Suh; Beom-Jun Kim; Soo-Youn Lee; Sail Chun; Jung-Min Koh; Seung Hun Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-08-02       Impact factor: 3.633

3.  A system view and analysis of essential hypertension.

Authors:  Alon Botzer; Ehud Grossman; John Moult; Ron Unger
Journal:  J Hypertens       Date:  2018-05       Impact factor: 4.844

Review 4.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

5.  Misdiagnosis of a hidden cause of hypertension: a case report.

Authors:  Andrés de Lima; Farah El-Sharkawy; Carol Nieroda; Armando Sardi
Journal:  Br J Gen Pract       Date:  2017-12       Impact factor: 5.386

Review 6.  Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor.

Authors:  Marco Grasso; Marco Boscaro; Carla Scaroni; Filippo Ceccato
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-10

Review 7.  Resistant Hypertension: A Real Entity Requiring Special Treatment?

Authors:  Stefano Taddei; Rosa Maria Bruno
Journal:  Eur Cardiol       Date:  2016-08

8.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 9.  Resistant Hypertension: An Incurable Disease or Just a Challenge For Our Medical Skill?

Authors:  Marina Di Pilla; Rosa Maria Bruno; Stefano Taddei
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-17

Review 10.  Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient.

Authors:  Rosa Maria Bruno; Stefano Taddei; Claudio Borghi; Furio Colivicchi; Giovambattista Desideri; Guido Grassi; Alberto Mazza; Maria Lorenza Muiesan; Gianfranco Parati; Roberto Pontremoli; Bruno Trimarco; Massimo Volpe; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.